David Pérez
Impact in
- Oncology top 10%
- Cancer survivorship and care
- Cancer Treatment and Pharmacology
Papers in
- Oncology 20
- Cancer survivorship and care 6
- Cancer Treatment and Pharmacology 4
-
- FOXO transcription factor regulation 4
- Co-authors
- Jenny Morris (1 shared paper)Bronwen McNoe (1 shared paper)V.J. Harvey (3 shared papers)Jahir Orozco (3 shared papers)P J Dady (3 shared papers)Nicolai Cramer (1 shared paper)Tanguy Saget (1 shared paper)Paul Glue (1 shared paper)
- Journals
- Quality of Life Research (3 papers)Cancer Chemotherapy and Pharmacology (3 papers)Journal of Health Psychology (2 papers)Journal of Clinical Oncology (2 papers)Australian Journal of Chemistry (1 paper)
- Partner nations
- New ZealandMexicoAustralia
In The Last Decade
David Pérez
56 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 139
- Oncology 321
- Biological Psychiatry 25
- Cancer Research 93
- Organic Chemistry 171
- Dermatology 48
Countries citing papers authored by David Pérez
This map shows the geographic impact of David Pérez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Pérez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Pérez more than expected).
Fields of papers citing papers by David Pérez
This network shows the impact of papers produced by David Pérez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Pérez. The network helps show where David Pérez may publish in the future.
Co-authors
The 25 scholars most cited alongside David Pérez, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 158 | |
| 2 | 1991 | 93 | |
| 3 | 1999 | 58 | |
| 4 | 2013 | 58 | |
| 5 | 2009 | 39 | |
| 6 | 2012 | 39 | |
| 7 | 2010 | 36 | |
| 8 | 2022 | 33 | |
| 9 | 2018 | 32 | |
| 10 | 1997 | 32 | |
| 11 | 2011 | 29 | |
| 12 | 2009 | 25 | |
| 13 | 2016 | 25 | |
| 14 | 2001 | 24 | |
| 15 | 1992 | 23 | |
| 16 | 2016 | 22 | |
| 17 | 2016 | 21 | |
| 18 | 2016 | 19 | |
| 19 | 2019 | 19 | |
| 20 | 2007 | 18 |
About David Pérez
David Pérez is a scholar working on Oncology, Molecular Biology, Organic Chemistry, Public Health, Environmental and Occupational Health and General Health Professions, having authored 60 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer survivorship and care (6 papers), Palliative Care and End-of-Life Issues (5 papers), Cancer Treatment and Pharmacology (4 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers), FOXO transcription factor regulation (4 papers), Patient-Provider Communication in Healthcare (4 papers), Synthesis and biological activity (4 papers) and Childhood Cancer Survivors' Quality of Life (3 papers). The work is most often cited by research in Oncology (321 citations), Biological Psychiatry (25 citations), Cancer Research (93 citations), Organic Chemistry (171 citations) and Dermatology (48 citations). David Pérez has collaborated with scholars based in New Zealand, Mexico and Australia. Frequent co-authors include Jenny Morris, Bronwen McNoe, V.J. Harvey, Jahir Orozco, P J Dady, Nicolai Cramer, Tanguy Saget, Paul Glue, Christopher H. Atkinson and B D Evans. Their work appears in journals such as Quality of Life Research, Cancer Chemotherapy and Pharmacology, Journal of Health Psychology, Journal of Clinical Oncology and Australian Journal of Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.